- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
- Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
- Haemonetics Corporation Completes Acquisition of Attune Medical
- Haemonetics Announces Definitive Agreement to Acquire Attune Medical
- Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference
- Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day
- Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
More ▼
Key statistics
As of last trade Haemonetics Corp (HAE:NYQ) traded at 89.22, -6.34% below its 52-week high of 95.26, set on Aug 08, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 87.49 |
---|---|
High | 89.50 |
Low | 87.49 |
Bid | 89.10 |
Offer | 89.23 |
Previous close | 87.66 |
Average volume | 451.73k |
---|---|
Shares outstanding | 50.79m |
Free float | 50.40m |
P/E (TTM) | 35.47 |
Market cap | 4.45bn USD |
EPS (TTM) | 2.47 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 18:50 BST.
More ▼